NCT01788592招募中不适用
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice
Seung-Jung Park1 个研究点 分布在 1 个国家目标入组 50,000 人开始时间: 2003年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50,000
- 试验地点
- 1
- 主要终点
- Major Adverse Cardiac Event
研究概览
简要总结
The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •coronary disease amenable to percutaneous coronary intervention (PCI)
- •no clinical and lesion limitations
排除标准
- •patients with a mixture of several drug eluting stents
- •terminal illness with life expectancy less than 1 year
- •patients with cardiogenic shock
结局指标
主要结局
Major Adverse Cardiac Event
时间窗: 1year
Death from any causes, myocardial infarction or any repeat revascularization
次要结局
- Stent thrombosis by Academic Research Consortium criteria(1year)
- Myocardial Infarction(1year)
- Target vessel revascularization(1year)
- all cause Death(1year)
- The composite of Death or myocardial infarction(1year)
- New lesion revascularization(1year)
- Target lesion revascularization(1year)
- Any repeat revascularization(1year)
研究者
Seung-Jung Park
MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine
Asan Medical Center
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical PracticePercutaneous Transluminal Coronary AngioplastyCoronary Artery DiseaseNCT01186133Seung-Jung Park50,000
已完成
4 期
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft LesionsArteriosclerosis of Arterial Coronary Artery Bypass GraftNCT00611910Deutsches Herzzentrum Muenchen610
终止
4 期
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)Coronary Artery DiseaseNCT01078051Seung-Jung Park840
已完成
不适用
Evaluating the Safety and Efficacy of the Maurora® DES in ICASIntracranial ArteriosclerosisStroke (CVA) or TIANCT05719883Beijing Tiantan Hospital156
Unknown
不适用
Retrospective Study of the Impact of Drug Eluting StentsCoronary Artery DiseaseNCT00487604Providence Health & Services9,800